🔴 LIVE: The Secrets of ProPicks AI Success Revealed + November’s List FREEWatch Now

Trial witness against Theranos' Elizabeth Holmes sues Disney, Hulu over miniseries

Published 03/23/2023, 05:51 PM
Updated 03/23/2023, 06:11 PM
© Reuters. FILE PHOTO: Theranos founder Elizabeth Holmes arrives to attend her fraud trial at federal court in San Jose, California, U.S., December 16, 2021.  REUTERS/Peter DaSilva/File Photo
DIS
-
CMCSA
-

By Jonathan Stempel

NEW YORK (Reuters) - A key prosecution witness whose testimony helped convict Theranos founder Elizabeth Holmes of fraud sued Walt Disney (NYSE:DIS) Co on Thursday over a recent Hulu miniseries that he says defamed him by portraying him as corrupt.

Adam Rosendorff, a former Theranos lab director, objected in a New York state court filing to a fictional character who held the same job in "The Dropout," which starred Amanda Seyfried as Holmes, chronicling her rise and fall at the blood-testing startup.

Rosendorff said the character, Mark Roessler, covered up Theranos' fraud by ordering the destruction of damaging lab results, falsifying records and engaging in other dishonest and unethical conduct.

According to Rosendorff, the portrayal has had a "devastating effect" on his reputation and career as a physician because media and even acquaintances have concluded that Roessler was based on him.

"At the time of the trial, (Rosendorff) was considered a heroic whistle-blower, a witness who was instrumental in the jury’s verdict convicting Holmes," the filing said. "Now he has been falsely portrayed as a perjurer, a criminal, and of being completely unfit to practice his profession."

"The Dropout" made its debut last March.

Neither Disney nor Hulu immediately responded to requests for comment. Disney owns 67% of Hulu, while Comcast Corp (NASDAQ:CMCSA)'s NBCUniversal owns 33%.

Richard Altman, a lawyer for Rosendorff, said neither he nor his client would have additional comment.

Holmes, 39, was found guilty in January 2022 and later sentenced to 11-1/4 years in prison for defrauding investors in Theranos, which was once valued at $9 billion.

© Reuters. FILE PHOTO: Theranos founder Elizabeth Holmes arrives to attend her fraud trial at federal court in San Jose, California, U.S., December 16, 2021.  REUTERS/Peter DaSilva/File Photo

Now a mother of two young children, Holmes is trying to delay her sentence while she appeals her conviction. Prosecutors have opposed a delay, calling Holmes a flight risk.

The case is Rosendorff v Hulu LLC et al, New York State Supreme Court, New York County, No. 152734/2023.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.